Rate and predictors of treatment prescription for hepatitis C
- PMID: 17005764
- PMCID: PMC1856823
- DOI: 10.1136/gut.2006.099150
Rate and predictors of treatment prescription for hepatitis C
Abstract
Background: The true treatment rate for hepatitis C virus (HCV) in veterans is unknown.
Aim: To determine the treatment prescription rates and predictors of treatment prescription for HCV in a large national population.
Methods: The Department of Veterans Affairs National Patient Care Database (NPCD) was used to identify all HCV-infected people between the fiscal years 1999 and 2003 using the International classification of diseases, 9th revision codes. Demographic information, medical and psychiatric comorbidities, and drug and alcohol use diagnoses were retrieved. Pharmacy data were retrieved from the Department of Veterans Affairs Pharmacy Benefits Management (PBM) database. Logistic regression analysis was used to determine the predictors of treatment for HCV in HCV.
Results: 113 927 veterans in the Department of Veterans Affairs care with a diagnosis of HCV were identified. The treatment prescription rate for HCV was 11.8%. Patients not prescribed treatment were older, more likely to be from minority races, have more alcohol and drug misuse, and have medical and psychiatric comorbid conditions. In a multivariate logistic regression model, the following factors were predictive of non-treatment for HCV: increasing age (odds ratio (OR) 0.77 for each 5-year increase in age; 95% confidence interval (CI) 0.76 to 0.78); black race (OR 0.64; 95% CI 0.6 to 0.68); Hispanic race (OR 0.88; 95% CI 0.8 to 0.96); alcohol abuse and dependence (OR 0.62; 95% CI 0.59 to 0.65); drug abuse and dependence (OR 0.78; 95% CI 0.74 to 0.82); anaemia (OR 0.18; 95% CI 0.16 to 0.21); hepatitis B infection (OR 0.72; 95% CI 0.62 to 0.83); coronary artery disease (OR 0.9; 95% CI 0.85 to 0.97); stroke (OR 0.75; 95% CI 0.67 to 0.85); bipolar disorder (OR 0.64; 95% CI 0.58 to 0.70); major depression (OR 0.72; 95% CI 0.67 to 0.77); mild depression (OR 0.56; 95% CI 0.53 to 0.59); and schizophrenia (OR 0.71; 95% CI 0.65 to 0.77). The following factors were associated with a higher likelihood of treatment prescription for HCV: liver cirrhosis (OR 1.6; 95% CI 1.5 to 1.7); and diabetes (OR 1.07; 95% CI 1.02 to 1.12).
Conclusions: A small number of HCV-infected veterans were prescribed treatment for HCV. Non-treatment is associated with increasing age, non-white race, drug and alcohol abuse, and dependence and comorbid illnesses. Reasons for non-treatment need further study.
Conflict of interest statement
Competing interests: None.
Similar articles
-
Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects.Aliment Pharmacol Ther. 2006 Aug 15;24(4):585-91. doi: 10.1111/j.1365-2036.2006.03020.x. Aliment Pharmacol Ther. 2006. PMID: 16907891
-
Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans.J Viral Hepat. 2007 Dec;14(12):890-6. doi: 10.1111/j.1365-2893.2007.00885.x. J Viral Hepat. 2007. PMID: 18070293
-
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.Am J Gastroenterol. 2005 Aug;100(8):1772-9. doi: 10.1111/j.1572-0241.2005.41860.x. Am J Gastroenterol. 2005. PMID: 16086714
-
Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review.J Clin Psychiatry. 2008 May;69(5):810-6. doi: 10.4088/jcp.v69n0514. J Clin Psychiatry. 2008. PMID: 18426262 Review.
-
Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.Infect Dis Clin North Am. 2018 Jun;32(2):281-292. doi: 10.1016/j.idc.2018.02.011. Infect Dis Clin North Am. 2018. PMID: 29778256 Review.
Cited by
-
Addressing hepatitis C in the foreign-born population: A key to hepatitis C virus elimination in Canada.Can Liver J. 2018 Jul 17;1(2):34-50. doi: 10.3138/canlivj.1.2.004. eCollection 2018 Spring. Can Liver J. 2018. PMID: 35990716 Free PMC article. Review.
-
Outcomes of treatment for hepatitis C virus infection by primary care providers.N Engl J Med. 2011 Jun 9;364(23):2199-207. doi: 10.1056/NEJMoa1009370. Epub 2011 Jun 1. N Engl J Med. 2011. PMID: 21631316 Free PMC article.
-
Health disparities in diagnosis and treatment of hepatocellular carcinoma.Clin Liver Dis (Hoboken). 2015 Jan 20;4(6):143-145. doi: 10.1002/cld.427. eCollection 2014 Dec. Clin Liver Dis (Hoboken). 2015. PMID: 30992943 Free PMC article. Review. No abstract available.
-
The impact of ethnicity on hepatitis C virus treatment decisions and outcomes.Dig Dis Sci. 2013 Mar;58(3):621-9. doi: 10.1007/s10620-012-2392-0. Epub 2012 Oct 12. Dig Dis Sci. 2013. PMID: 23065087 Review.
-
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).BMC Health Serv Res. 2012 Mar 12;12:59. doi: 10.1186/1472-6963-12-59. BMC Health Serv Res. 2012. PMID: 22409788 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical